XML 22 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Revenue:      
Revenue $ 424,046 $ 444,849 $ 388,225
Cost of sales:      
Amortization 3,813 3,962 5,297
Total cost of sales 174,140 192,646 171,939
Gross profit 249,906 252,203 216,286
Operating expenses:      
Sales and marketing 83,278 81,681 70,366
Research and development 60,289 58,648 55,098
General and administrative 58,250 61,779 58,802
Change in fair value of contingent consideration 0 0 (6,200)
Total operating expenses 201,817 202,108 178,066
Operating income 48,089 50,095 38,220
Other expense, net:      
Interest expense, net (15,415) (25,236) (19,690)
Other (expense) income, net (94) 59 98
Total other expense, net (25,231) (25,177) (19,592)
Income before income taxes 22,858 24,918 18,628
Income tax expense (benefit) 353 148 (755)
Net income $ 22,505 $ 24,770 $ 19,383
Net income per common share:      
Basic $ 0.62 $ 0.69 $ 0.55
Diluted net income per common share:      
Diluted $ 0.61 $ 0.67 $ 0.54
Weighted average common shares:      
Basic (shares) 36,316,000 35,820,000 35,031,000
Diluted (shares) 36,984,000 36,869,000 35,995,000
Deferred Debt Issuance Cost, Writeoff $ (9,722) $ 0 $ 0
Product      
Revenue:      
Revenue 304,540 331,162 290,170
Cost of sales:      
Cost of sales 144,790 161,451 140,615
Service      
Revenue:      
Revenue 119,506 113,687 98,055
Cost of sales:      
Cost of sales $ 25,537 $ 27,233 $ 26,027